Health Condition 1: G239- Degenerative disease of basal ganglia, unspecified Health Condition 2: G318- Other specified degenerative diseases of nervous system Health Condition 3: G231- Progressive supranuclear ophthalmoplegia [Steele-Richardson-Olszewski]
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: We shall include Parkinson-plus patients visiting the Neurology OPDs and/or emergencies. Hence, we will include patients of Progressive Supranuclear Palsy including PSP-CBS [18], Dementia of Lewy Body disease [19] and Multiple system atrophy [20], who consent for the study. We shall include only those patients who have an MMSE (Mini Mental Status Examination) score of greater than 20, so that they would be able to understand the instructions given to them.
Exclusion criteria
Exclusion criteria: We shall exclude patients having a MMSE of less than 21 and those who do not give consent for the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| We would measure primary outcome in terms of improvement or stabilization of UPDRS, MMSE, lobar functions, gait testing, PHQ9, GAD7 and also EEG parametersTimepoint: 1 month 2 months 3 months | — |
Secondary
| Measure | Time frame |
|---|---|
| Secondary outcome would include any adverse effects noted following music like headache, fatigue, muscle pains or irritabilityTimepoint: 1 month 2 months 3 months | — |
Countries
India
Contacts
SGPGIMS, Lucknow